Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial

Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study

(2015) Eugenia Mamikonyan et al.   MOVEMENT DISORDERS

Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

(2015) Laura Brennan et al.   MOVEMENT DISORDERS

Advances in the treatment of cognitive impairment in Parkinson's disease

(2015) Jennifer G. Goldman et al.   MOVEMENT DISORDERS

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

(2015) Kara M. Smith et al.   JAMA Neurology

Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies

(2014) Keith A. Wesnes et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis

(2013) A. C. Tricco et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

(2011) Hasmet A. Hanagasi et al.   MOVEMENT DISORDERS

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI

(2011) Irene Litvan et al.   MOVEMENT DISORDERS

Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment

(2010) Charles H. Adler et al.   ACTA NEUROPATHOLOGICA

Is quality of life in non-demented Parkinson’s disease patients related to cognitive performance? A clinic-based cross-sectional study

(2010) N. Klepac et al.   EUROPEAN JOURNAL OF NEUROLOGY

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

(2010) Angie A Kehagia et al.   LANCET NEUROLOGY

Association between cognition and function in patients with Parkinson disease with and without dementia

(2010) Emily Rosenthal et al.   MOVEMENT DISORDERS

Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis

(2010) D. Aarsland et al.   NEUROLOGY

Characteristics and Performance of a Modified Version of the ADCS-CGIC CIBIC+ for Mild Cognitive Impairment Clinical Trials

(2009) Lon S. Schneider et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

(2009) Daniel Weintraub et al.   MOVEMENT DISORDERS

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

(2009) Paolo Barone et al.   MOVEMENT DISORDERS

Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression?

(2008) Julie H. Carter et al.   MOVEMENT DISORDERS